<body><script type="text/javascript"> function setAttributeOnload(object, attribute, val) { if(window.addEventListener) { window.addEventListener('load', function(){ object[attribute] = val; }, false); } else { window.attachEvent('onload', function(){ object[attribute] = val; }); } } </script> <div id="navbar-iframe-container"></div> <script type="text/javascript" src="https://apis.google.com/js/platform.js"></script> <script type="text/javascript"> gapi.load("gapi.iframes:gapi.iframes.style.bubble", function() { if (gapi.iframes && gapi.iframes.getContext) { gapi.iframes.getContext().openChild({ url: 'https://www.blogger.com/navbar/5621345630369022014?origin\x3dhttp://cderwn.blogspot.com', where: document.getElementById("navbar-iframe-container"), id: "navbar-iframe" }); } }); </script>

Drug Evaluation & Research

CDERNEW-TEXT 10/29 & 30/2007


Wednesday, October 31, 2007

October 30, 2007

Guidance for Industry: Role of HIV Resistance Testing in Antiretroviral
Drug Development [PDF http://www.fda.gov/cder/guidance/7688fnl.pdf ]

Postmarketing Study Commitments Search
http://www.accessdata.fda.gov/scripts/cder/pmc/index.cfm

(updated)

October 29, 2007

CellCept (mycophenolate mofetil)
http://www.fda.gov/medwatch/safety/2007/safety07.htm#CellCept2 - Changes
to prescribing information due to increased risk of first trimester
pregnancy loss and increased risk of congenital malformations.

Guidance for Industry: Acute Bacterial Sinusitis: Developing Drugs for
Treatment [PDF http://www.fda.gov/cder/guidance/3895dft.pdf ]

New and Generic Drug Approvals
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm

Epirubicin Hydrochloride Injection, Watson Labs, Approval

Omeprazole Delayed-release Capsules 10 & 20mg, Apotex, Approval

Omeprazole Delayed-release Capsules 10 & 20mg, Impax Labs, Approval

Omeprazole Delayed-release Capsules 10 & 20mg, Dr. Reddy's Labs,
Approval

Renagel (sevelamer hydrochloride) Tablets, Genzyme Corp., Efficacy Supp.
w/Clinical Data

Renvela (sevelamer carbonate) Tablets, Genzyme Corp., Approval

Rivastigmine Tartrate Capsules, Sun Pharma, Approval

Stimate (desmopressin acetate) Nasal Spray, CSL Behring, Formulation
Revision

Tasigna Oral Capsule, Novartis, Approval

Valsartan Tablet, Ranbaxy Labs, Tentative Approval

Zithromax (azithromycin) 250mg Capsules, Pfizer, Labeling Revision

Zithromax (azithromycin) Single-Dose Packet, Pfizer, Labeling Revision

Zithromax (azithromycin) 600mg Tablet, Pfizer, Labeling Revision

Zithromax (azithromycin) Oral Suspension, Pfizer Inc., Labeling Revision


Zithromax (azithromycin) 250mg Tablet, Pfizer Inc., Labeling Revision

Zithromax (azithromycin) 500mg Tablet, Pfizer Inc., Labeling Revision

Zithromax IV (azithromycin) Injection, Pfizer, Labeling Revision

Zmax (azithromycin extended release) Oral Suspension, Labeling Revision

------------------------------------------------
To subscribe or to unsubscribe from CDERNEW-TEXT

http://list.nih.gov/archives/cdernew-text.html
------------------------------------------------

posted by Mags @ 8:47 AM,




0 Comments:

Post a Comment

<< Home